The WHEAT International trial is a comparative effectiveness trial exploring whether withholding enteral feeds around the time of blood transfusion in very premature infants (\<30 weeks) will reduce the occurrence of Necrotizing Enterocolitis (NEC). Currently both continued feeding and withholding feeding are approved care practices. The current study will randomize infants from Neonatal Intensive Care Units (NICUs) across Canada and the United Kingdom (UK) into one of the two care approaches (withholding or continued feeds) to determine if any significant outcomes are found.
BACKGROUND: Necrotizing enterocolitis (NEC) is a devastating disease that affects mostly the intestine of premature infants. The wall of the intestine is invaded by bacteria, which cause local infection and inflammation that can ultimately destroy the wall of the bowel (intestine). NEC is among the most potentially devastating neonatal diseases and has a mortality of up to 33%, the most severe form (requiring surgery or resulting in death) affects about 5% of infants born at less than 30 gestational weeks; survivors are at high risk of long-term health and developmental problems. Prevention of NEC has been identified as one of the most important research uncertainties in the field of preterm birth. A temporal association between red cell transfusion and the subsequent development of the disease is well described. This 'transfusion-associated NEC' may also be more severe with higher mortality. Very preterm or extremely low birth weight infants are among the most frequently transfused patients: between 56% and 90-95% have at least one transfusion, and those transfused received an average of 5 transfusions in their neonatal stay. Withholding milk feeds during red cell transfusion may reduce the risk of NEC by decreasing postprandial mesenteric ischemia but there may be harmful effects of pausing enteral feeds. However, due to a lack of good quality evidence, there is no consensus regarding the optimal feeding strategy during a blood transfusion. Both comparator pathways of care are standard practice in Canada and the UK; the WHEAT trial is a comparative effectiveness trial. The two care pathways that will be compared are: 1. Withholding Feeds Around Transfusion: All enteral feeds will be discontinued (the infant will be placed nil by mouth) for 4 hours prior to packed red cell transfusion, during the packed red cell transfusion and until 4 hours post packed red cell transfusion. 2. Continuing Feeds Around Transfusion: Enteral feeds will continue to be given prior, during and after the packed red cell transfusion, in the manner in which they were being given prior to the decision to transfuse. Infants will remain allocated to the same care pathway until 34(+6) weeks(+days) gestational age.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
4,333
Withholding enteral feeds for preterm infants (\<30 weeks) around the time of blood transfusions to determine if any impact on the development and/or severity of Necrotizing Enterocolitis.
Continued enteral feeds
IWK Health
Halifax, Nova Scotia, Canada
RECRUITINGNEC Stage II
NEC stage II or more after the first transfusion (modified Bell staging criteria) - Clinical signs and symptoms plus pneumatosis or portal/hepatic air diagnosed by x-ray or other imaging techniques
Time frame: From randomization to 40 weeks postmenstrual age
Severe NEC
Histologically or surgically confirmed or recorded on the death certificate. These infants will be identified as described in Battersby et al. which will include infants recorded as being transferred for surgery.
Time frame: From randomization to 40 weeks postmenstrual age
Death
All-cause mortality
Time frame: From randomization to 40 weeks postmenstrual age
Late onset sepsis
Culture positive sepsis, onset after 72 hours of life
Time frame: From randomization to 40 weeks postmenstrual age
Number of days with a central venous line in situ
Number of days with a central venous line in situ
Time frame: From birth to date of discharge home
Number of central line associated bloodstream infections
Includes laboratory-confirmed bloodstream infection and clinical sepsis
Time frame: From randomization to 40 weeks postmenstrual age
Duration of any parenteral nutrition in days
Duration of any parenteral nutrition in days
Time frame: From birth to 40 weeks postmenstrual age
Growth
Weight and head circumference z score.
Time frame: At date of discharge home
Spontaneous Intestinal Perforation
Histologically or surgically confirmed or recorded in the death certificate.
Time frame: From randomization to 40 weeks postmenstrual age
Duration of hospital stay
Total duration of neonatal care in days including all levels of care (intensive care, high dependency care, special care and ordinary care)
Time frame: From birth to date of discharge home
Bronchopulmonary Dysplasia (BPD)/Chronic Lung Disease
Requiring respiratory support at 36 weeks gestation
Time frame: At 36 weeks postmenstrual age
Retinopathy of prematurity (ROP)
ROP requiring treatment
Time frame: From randomization to 40 weeks postmenstrual age
Severe Brain Injury
Intraventricular haemorrhage (IVH) grade 3 or 4 or cystic periventricular leukomalacia (PVL)
Time frame: At 40 weeks postmenstrual age
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.